ATE52080T1 - Piperidinole und aryloxymethyl-pyrrolidinole mit blutdrucksenkenden, antidepressiven und antiarrhythmischen wirkungen. - Google Patents

Piperidinole und aryloxymethyl-pyrrolidinole mit blutdrucksenkenden, antidepressiven und antiarrhythmischen wirkungen.

Info

Publication number
ATE52080T1
ATE52080T1 AT85300667T AT85300667T ATE52080T1 AT E52080 T1 ATE52080 T1 AT E52080T1 AT 85300667 T AT85300667 T AT 85300667T AT 85300667 T AT85300667 T AT 85300667T AT E52080 T1 ATE52080 T1 AT E52080T1
Authority
AT
Austria
Prior art keywords
piperidinols
hyperpressor
arhythmic
pyrrolidinols
aryloxymethyl
Prior art date
Application number
AT85300667T
Other languages
English (en)
Inventor
Chandler Roy Taylor Jr
Harold Fisher Stauffer Jr
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Application granted granted Critical
Publication of ATE52080T1 publication Critical patent/ATE52080T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
AT85300667T 1984-02-03 1985-01-31 Piperidinole und aryloxymethyl-pyrrolidinole mit blutdrucksenkenden, antidepressiven und antiarrhythmischen wirkungen. ATE52080T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/576,904 US4508724A (en) 1984-02-03 1984-02-03 Aryloxymethylpyrrolidinols and piperidinols having antidepressant, antiarrhythmic or hypotensive activity
EP85300667A EP0152236B1 (de) 1984-02-03 1985-01-31 Piperidinole und Aryloxymethyl-Pyrrolidinole mit blutdrucksenkenden, antidepressiven und antiarrhythmischen Wirkungen

Publications (1)

Publication Number Publication Date
ATE52080T1 true ATE52080T1 (de) 1990-05-15

Family

ID=24306486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85300667T ATE52080T1 (de) 1984-02-03 1985-01-31 Piperidinole und aryloxymethyl-pyrrolidinole mit blutdrucksenkenden, antidepressiven und antiarrhythmischen wirkungen.

Country Status (6)

Country Link
US (1) US4508724A (de)
EP (1) EP0152236B1 (de)
JP (1) JPS60163861A (de)
AT (1) ATE52080T1 (de)
CA (1) CA1257277A (de)
DE (1) DE3577196D1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63192751A (ja) * 1987-02-06 1988-08-10 Ube Ind Ltd ４−ヒドロキシピペリジンの製造方法
US5231184A (en) * 1987-11-23 1993-07-27 Janssen Pharmaceutica N.V. Pridazinamine derivatives
US4927634A (en) * 1987-12-16 1990-05-22 Richardson-Vicks Inc. Pharmaceutical compositions containing dyclonine HC1 and phenol
DE3814517A1 (de) * 1988-02-05 1989-08-17 Bayer Ag Chinolon- und naphthyridoncarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
AU5358490A (en) * 1989-04-07 1990-11-05 Fujisawa Pharmaceutical Co., Ltd. New naphthalene compounds and method of producing the same
US5169855A (en) * 1990-03-28 1992-12-08 Du Pont Merck Pharmaceutical Company Piperidine ether derivatives as psychotropic drugs or plant fungicides
US5693691A (en) * 1995-08-21 1997-12-02 Brewer Science, Inc. Thermosetting anti-reflective coatings compositions
US6110937A (en) * 1997-04-03 2000-08-29 Syntex Usa, Inc. Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain
EP1182192A4 (de) * 1999-04-09 2002-06-05 Mochida Pharm Co Ltd 4-hydroxypiperidin-derivate mit antiarrhythmischem effekt
JP2005097120A (ja) * 2000-10-06 2005-04-14 Mochida Pharmaceut Co Ltd ４−ヒドロキシピペリジン誘導体の非潮解性塩
JP4544999B2 (ja) * 2002-11-25 2010-09-15 持田製薬株式会社 ４−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤
DE102012006884A1 (de) 2012-04-04 2013-10-10 Merck Patent Gmbh Cyclische Amide als MetAP-2 Inhibitoren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3446897A (en) * 1966-09-30 1969-05-27 Robins Co Inc A H Compositions and methods for the control of cardiac arrhythmia with o-substituted pyrrolidinols and s-substituted thiopyrrolidinols
US3679666A (en) * 1969-04-03 1972-07-25 Hoffmann La Roche 4-(4-hydroxypiperidino)-4'-fluorobutyrophenones

Also Published As

Publication number Publication date
DE3577196D1 (de) 1990-05-23
JPS60163861A (ja) 1985-08-26
EP0152236B1 (de) 1990-04-18
EP0152236A3 (en) 1987-05-13
US4508724A (en) 1985-04-02
CA1257277A (en) 1989-07-11
EP0152236A2 (de) 1985-08-21

Similar Documents

Publication Publication Date Title
SE9604786D0 (sv) New compounds
IT8567165A1 (it) Composizioni a base di liposomi, particolarmente per mantenere ed immobilizzare una riserva di agenti biologicamente attivi, e relativo procedimento d'impiego.
ATE52080T1 (de) Piperidinole und aryloxymethyl-pyrrolidinole mit blutdrucksenkenden, antidepressiven und antiarrhythmischen wirkungen.
ATE45731T1 (de) 3-substituierte 2-oxindole-1-carboxamide, als analgetische und antiinflammatorische mittel verwendet.
ATE72448T1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
ATE86252T1 (de) Indolsaeureverbindungen und ihre anwendung als antiallergische heilmittel.
FI88717C (fi) Foerfarande foer framstaellning av som laekemedel anvaendbara cyklopenta/d/pyrimidinderivat
ES2142773A1 (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
DE3585980D1 (de) Hydrazinderivate und ihre verwendung.
ATE174508T1 (de) Verwendung von bis (amidinobenzidazolen) zur herstellung eines medikamentes für die hemmung der retroviral integrase
FI851261L (fi) Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
DE69001722D1 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
GB1426028A (en) 2-oxazoline derivatives
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
ES553412A0 (es) Un procedimiento para la produccion de derivados de benzoilurea
DK45486D0 (da) Anti-inflammatorisk praeparat
IT1178709B (it) Diacilderivati della glicerilfosforilcolina ad attivita'terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
DE3588094D1 (de) Antihypertensive Derivate
TW357140B (en) Substituted benzenesulfonylureas and -thioureas having cardiac activity, processes for their preparation, and the pharmaceutical compositions thereof
SE9603284D0 (sv) New compounds
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
DK353785D0 (da) 2,5-pyrrolidindionderivater
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
ES479005A1 (es) Un procedimiento para obtener derivados de quinazolina.
DE68918240T2 (de) 1,4-Dihydropyridin-Derivate.